CODX Key Statistics, Chart & Performance
The current stock price of CODX is 2.36 USD. In the past month the price decreased by -76.96%. In the past year, price decreased by -90.1%.
CODX Technical Analysis
CODX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CODX. No worries on liquidiy or solvency for CODX as it has an excellent financial health rating, but there are worries on the profitability.
CODX Financial Highlights
Over the last trailing twelve months CODX reported a non-GAAP Earnings per Share(EPS) of -19.26. The EPS decreased by -1416.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -71.93% | ||
| ROE | -80.8% | ||
| Debt/Equity | 0 |
CODX Forecast & Estimates
8 analysts have analysed CODX and the average price target is 38.25 USD. This implies a price increase of 1520.76% is expected in the next year compared to the current price of 2.36.
For the next year, analysts expect an EPS growth of -1795.58% and a revenue growth -88.3% for CODX
CODX Ownership
CODX Latest News, Press Relases and Analysis
About CODX
Company Profile
Co-Diagnostics Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Salt Lake City, Utah and currently employs 132 full-time employees. The company went IPO on 2017-07-12. Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The firm also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. The company is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Company Info
CO-DIAGNOSTICS INC
2401 S. Foothill Dr. Suite D
Salt Lake City UTAH 84109 US
CEO: Dwight Egan
Employees: 132
Phone: 18014381036
CO-DIAGNOSTICS INC / CODX FAQ
What does CO-DIAGNOSTICS INC do?
Co-Diagnostics Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Salt Lake City, Utah and currently employs 132 full-time employees. The company went IPO on 2017-07-12. Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The firm also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. The company is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
What is the stock price of CO-DIAGNOSTICS INC today?
The current stock price of CODX is 2.36 USD. The price decreased by -60.54% in the last trading session.
Does CODX stock pay dividends?
CODX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CODX stock?
CODX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the market capitalization of CODX stock?
CO-DIAGNOSTICS INC (CODX) has a market capitalization of 143.70M USD. This makes CODX a Micro Cap stock.
What is the next earnings date for CODX stock?
CO-DIAGNOSTICS INC (CODX) will report earnings on 2026-03-25, after the market close.